Citing competitive pressures in the US, Novo Nordisk A/S has announced plans to reduce its workforce by about 1,000 employees – or 2.4% of its global staff of 42,300 persons. The measures do not alter the company’s forecast for 2016 which calls for increases in sales and operating profit.
